Table 1 Protein expression of DACT1, DACT2 and DACT3 in ESCC Cases
Group | N | DACT1 Protein | DACT2 Protein | ||
|---|---|---|---|---|---|
positive n (%) | p | positive n (%) | p | ||
Age | |||||
 <60 | 74 | 44(59.5%) | 0.935 | 37(50.0%) | 0.337 |
 ≥60 | 85 | 50(58.8%) |  | 49(57.6%) |  |
Gender | |||||
 Male | 93 | 56(60.2%) | 0.739 | 49(52.7%) | 0.674 |
 Female | 66 | 38(57.6%) |  | 37(56.1%) |  |
Histological grade | |||||
 Well/moderate | 98 | 58(59.2%) | 0.983 | 54(55.1%) | 0.483 |
 poor | 61 | 36(59.0%) |  | 32(52.5%) |  |
clinical stage | |||||
 I + II | 86 | 59(68.6%) | 0.008 | 53(61.6%) | 0.038 |
 III + IV | 73 | 35(47.9%) |  | 33(45.2%) |  |
Lymph node | |||||
 + | 121 | 66(54.5%) | 0.036 | 57(47.1%) | 0.105 |
 - | 38 | 28(73.7%) |  | 29(76.3%) |  |
Family history of UGIC | |||||
 + | 61 | 31(50.8%) | 0.093 | 26(42.6%) | 0.022 |
 - | 98 | 63(64.3%) |  | 60(61.2%) |  |